Summit Therapeutics stock tumbles on $500M stock offering

Summit Therapeutics and Shattuck Labs both experienced stock price drops after announcing public offerings. Summit Therapeutics is launching a $500M stock offering, contributing to its share tumble. Similarly, Shattuck Labs saw its stock fall following its own public offering announcement. Both companies are utilizing these financial maneuvers to raise capital, which has resulted in immediate negative market reactions for their respective share prices as investors respond to the increased supply of equity.